Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 9, 2008, Pages 1147-1158

  Coron, E ^a   Sebille, V ^a   Cadiot, G ^b   Zerbib, F ^c   Ducrotte, P ^d   Ducrot, F ^e   Pouderoux, P ^f   Arts, J ^g   Le Rhun, M ^a   Piche, T ^h   Bruley Des Varannes, S ^a   Galmiche, J P ^a,i,j  

^a HÔTEL DIEU   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

^d HÔPITAL CHARLES NICOLLE   (France)

^e Clinique des Ormeaux Vauban Le Havre   (France)

^f Service d'Hépatogastroentérologie   (Tunisia)

^g AZ Sint Lucas   (France)

^h UNIVERSITY HOSPITAL OF NICE   (France)

ⁱ NANTES UNIVERSITY HOSPITAL   (France)

^j INSERM   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG UTILIZATION; DRUG WITHDRAWAL; ENDOSCOPIC THERAPY; ESOPHAGEAL ACID EXPOSURE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAINTENANCE THERAPY; MALE; OUTCOME ASSESSMENT; PARAMETER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIOFREQUENCY; RADIOFREQUENCY ENERGY DELIVERY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; TECHNIQUE; TREATMENT OUTCOME;

ADULT; CATHETER ABLATION; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 53549095217     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03790.x     Document Type: Article

References (34)

1. Locke GR III., Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 112 : 1448 56.
2. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004 22 : 108 14.
3. Chiba N. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. Can J Gastroenterol 1997 11 : 66B 73B.
4. Inadomi JM, McIntyre L, Bernard L, Fendrick AM. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol 2003 98 : 1940 4.
5. Hungin AP, Rubin GP, O'Flanagan H. Long-term prescribing of proton pump inhibitors in general practice. Br J Gen Pract 1999 49 : 451 3.
6. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004 292 : 1955 60.
7. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005 294 : 2989 95.
8. Geevasinga N, Coleman PL, Webster AC, Roger SD. Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol 2006 4 : 597 604.
9. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006 296 : 2947 53.
10. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies of gastroesophageal reflux disease: follow-up a randomized controlled trial. JAMA 2001 285 : 2331 8.
11. Thibault R, Coron E, Sébille V, et al. Antireflux surgery for non-erosive and erosive reflux disease in community practice. Aliment Pharmacol Ther 2006 24 : 621 32.
12. Rantanen TK, Salo JA, Sipponen JT. Fatal and life-threatening complications in antireflux surgery: analysis of 5,502 operations. Br J Surg 1999 86 : 1573 7.
13. Arts J, Tack J, Galmiche JP. Endoscopic antireflux procedures. Gut 2004 53 : 1207 14.
14. Triadafilopoulos G, Dibaise JK, Nostrant TT, et al. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD. Gastrointest Endosc 2001 53 : 407 15.
15. Triadafilopoulos G, DiBaise JK, Nostrant TT, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc 2002 55 : 149 56.
16. Tam WC, Schoeman MN, Zhang Q, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut 2003 52 : 479 85.
17. Triadafilopoulos G. Changes in GERD symptom scores correlate with improvement in esophageal acid exposure after the Stretta procedure. Surg Endosc 2004 18 : 1038 44.
18. Lutfi RE, Torquati A, Kaiser J, Holzman M, Richards WO. Three year's experience with the Stretta procedure: did it really make a difference? Surg Endosc 2005 19 : 289 95.
19. Cipolletta L, Rotondano G, Dughera L, et al. Delivery of radiofrequency energy to the gastroesophageal junction (Stretta procedure) for the treatment of gastroesophageal reflux disease. Surg Endosc 2005 19 : 849 53.
20. Reymunde A, Santiago N. Long-term results of radiofrequency energy delivery for the treatment of GERD: sustained improvements in symptoms, quality of life, and drug use at 4-year follow-up. Gastrointest Endosc 2007 65 : 361 6.
21. Noar MD, Lotfi-Emran S. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure. Gastrointest Endosc 2007 65 : 367 72.
22. Meier PN, Nietzschmann T, Akin I, Klose S, Manns MP. Improvement of objective GERD parameters after radiofrequency energy delivery: a European study. Scand J Gastroenterol 2007 42 : 911 6.
23. Corley DA, Katz P, Wo JM, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology 2003 125 : 668 76.
24. Raymond JM, Marquis P, Bechade D, et al. Assessment of quality of life of patients with gastroesophageal reflux. Elaboration and validation of a specific questionnaire. Gastroenterol Clin Biol 1999 23 : 32 9.
25. McHorney CA, Ware JE Jr., Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994 32 : 40 66.
26. Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995 37 : 457 64.
27. Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994 107 : 1741 5.
28. Welch RW, Drake ST. Normal lower esophageal sphincter pressure: a comparison of rapid vs. slow pull-through techniques. Gastroenterology 1980 78 : 1446 51.
29. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999 45 : 172 80.
30. Moher D, Schulz KF, Altman D. CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001 285 : 1987 91.
31. Kim MS, Holloway RH, Dent J, Utley DS. Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs. Gastrointest Endosc 2003 57 : 17 22.
32. Utley DS, Kim M, Vierra MA, Triadafilopoulos G. Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal junction: a porcine model. Gastrointest Endosc 2000 52 : 81 6.
33. Arts J, Sifrim D, Rutgeerts P, Lerut A, Janssens J, Tack J. Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease. Dig Dis Sci 2007 52 : 2170 7.
34. Fleischer D. The Stretta procedure: technique, optimisation and complication rates (abstr.). Gastrointest Endosc 2002 55 : AB256.